Last edition
News about "Bayer Gene Therapy Trials"
The first participant has been dosed in the pivotal Phase III exPDite-2 trial of bemdaneprocel, an investigational cell therapy, while the first European participants have been enrolled in REGENERATE-PD, a Phase II trial of the gene therapy AB-1005.
Bayer Gene Therapy Trials | 23/09/2025 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members